US Patent Issued to Kling Biotherapeutics on Sept. 15 for "Epithelial cadherin-specific antibodies" (Dutch Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,498, issued on Sept. 15, was assigned to Kling Biotherapeutics B.V. (Amsterdam).

"Epithelial cadherin-specific antibodies" was invented by Tim Beaumont (Ouderkerk aan de Amstel, Netherlands), Sabrina Julia Louisa Merat ('s-Hertogenbosch, Netherlands), Mark Jeroen Kwakkenbos (Amsterdam), Martijn Kedde (Amsterdam) and Hergen Spits (Bergen, Netherlands).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to epithelial cadherin-specific antibodies, as well as uses thereof in the diagnosis and treatment of diseases such as cancer."

The patent was filed on Jan. 8, 2021, under Application No. 17/789,940.

*For further information,...